Close

Letter to James Rogan, Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization

May 6 2002

Report on the State of the Industry

Apr 29 2002
To Covance Senior Management, Carl Feldbaum

BIO's comments regarding the NPRM that proposes changes to the HIPAA privacy regulation

Apr 25 2002
Comments on Proposed Standards for Privacy of Individually Identifiable Health Information

Testimony of Charles A. Johnson, MBChB

Apr 23 2002
Testimony on behalf of the Biotechnology Industry Organization (BIO) before the Senate Committee on Health, Education, Labor and Pensions

Testimony of Charles A. Johnson, MBChB on behalf of the BIO before the Senate Committee on Health, Education, Labor and Pensions

Apr 23 2002

Testimony of Michael J. Werner, Esq. before the Committee on Health, Education, Labor, and Pensions, hearing on Medical Privacy

Apr 16 2002

Bayh-Dole and Technology Transfer

Apr 11 2002
The United States currently leads the world in the area of biotechnology because U.S. patent laws and legislation such as the Bayh-Dole Act have provided favorable incentives to mitigate the high risks.

BIO letter to the editor of the Washington Post clarifying the Bayh-Dole Act

Mar 29 2002

To Representative John Conyers

Mar 21 2002
Ranking Member of the House Judiciary Committee

To Representative Howard Coble

Mar 21 2002
Chairman of the House Judiciary Subcommittee on Courts, The Internet, and Intellectual Property